{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:32:11Z","timestamp":1774686731382,"version":"3.50.1"},"reference-count":78,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/gco.0b013e32833e1264","type":"journal-article","created":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T10:22:44Z","timestamp":1282213364000},"page":"466-476","source":"Crossref","is-referenced-by-count":29,"title":["Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update"],"prefix":"10.1097","volume":"22","author":[{"given":"Niki","family":"Katsiki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos I","family":"Hatzitolios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210129","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-6-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R3-6-20210129","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tem.2007.08.001","article-title":"The management of insulin resistance in polycystic ovary syndrome","volume":"18","author":"Teede","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3121\/cmr.2.1.13","article-title":"Polycystic ovarian syndrome: diagnosis and management","volume":"2","author":"Sheehan","year":"2004","journal-title":"Clin Med Res"},{"key":"R5-6-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2008-0030","article-title":"Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review","volume":"30","author":"Palomba","year":"2009","journal-title":"Endocr Rev"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2165\/00003495-200969110-00001","article-title":"The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome","volume":"69","author":"Katsiki","year":"2009","journal-title":"Drugs"},{"key":"R7-6-20210129","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1517\/14728220903190699","article-title":"Targeting insulin sensitivity in the treatment of polycystic ovary syndrome","volume":"13","author":"Pasquali","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"R8-6-20210129","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1471-0528.2006.00966.x","article-title":"The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"113","author":"Lord","year":"2006","journal-title":"BJOG"},{"key":"R9-6-20210129","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.ajog.2005.11.009","article-title":"Lipids in polycystic ovary syndrome: role of hyperinsulinemia and effects of metformin","volume":"194","author":"Banaszewska","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R10-6-20210129","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1210\/jc.2007-0441","article-title":"Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome","volume":"92","author":"Palomba","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-6-20210129","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double-blind placebo-controlled trial","volume":"87","author":"Fleming","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-6-20210129","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-6-20210129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1210\/jc.2007-0842","article-title":"Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment","volume":"93","author":"Heutling","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-6-20210129","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1177\/1933719109340925","article-title":"Metformin does not improve the reproductive or metabolic profile in women with polycystic ovary syndrome (PCOS)","volume":"16","author":"Aubuchon","year":"2009","journal-title":"Reprod Sci"},{"key":"R16-6-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09513590903215581","article-title":"Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, placebo control trial","volume":"8","author":"Fux Otta","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"R17-6-20210129","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/jc.2009-1985","article-title":"Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial","volume":"95","author":"Agarwal","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-6-20210129","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.fertnstert.2009.02.078","article-title":"An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome","volume":"94","author":"Karimzadeh","year":"2010","journal-title":"Fertil Steril"},{"key":"R21-6-20210129","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2337\/dc09-1516","article-title":"Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome","volume":"33","author":"Palomba","year":"2010","journal-title":"Diabetes Care"},{"key":"R22-6-20210129","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.fertnstert.2009.01.114","article-title":"Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo controlled trial","volume":"93","author":"Romualdi","year":"2010","journal-title":"Fertil Steril"},{"key":"R25-6-20210129","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.fertnstert.2008.10.058","article-title":"Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome","volume":"93","author":"Ozkaya","year":"2010","journal-title":"Fertil Steril"},{"key":"R26-6-20210129","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00404-008-0904-0","article-title":"The effect of metformin treatment on ovarian stromal blood flow in women with polycystic ovary syndrome","volume":"280","author":"Ozcimen","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"R28-6-20210129","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.fertnstert.2008.03.082","article-title":"Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome","volume":"91","author":"Luque-Ramirez","year":"2009","journal-title":"Fertil Steril"},{"key":"R29-6-20210129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2478\/v10042-009-0032-0","article-title":"Leptin concentrations in patients with polycystic ovary syndrome before and after metformin treatment depending on insulin resistance, body mass index and androgen concentrations-introductory report","volume":"47","author":"Marciniak","year":"2009","journal-title":"Folia Histochem Cytobiol"},{"key":"R30-6-20210129","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF03345790","article-title":"Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention","volume":"33","author":"Moran","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"R31-6-20210129","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/09513590802128968","article-title":"Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment","volume":"24","author":"Jakubowska","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"R32-6-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/oby.2008.491","article-title":"Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients","volume":"17","author":"Luque-Ramirez","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"R33-6-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/193229680700100212","article-title":"Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome","volume":"1","author":"Steiner","year":"2007","journal-title":"J Diabetes Sci Technol"},{"key":"R34-6-20210129","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.fertnstert.2007.11.069","article-title":"Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome","volume":"91","author":"Kj\u00f8tr\u00f8d","year":"2009","journal-title":"Fertil Steril"},{"key":"R35-6-20210129","first-page":"934","article-title":"Effects of short term metformin administration on androgens in normal men","volume":"23","author":"Shegem","year":"2002","journal-title":"Saudi Med J"},{"key":"R36-6-20210129","first-page":"75","article-title":"Effects of short term metformin administration on androgens in diabetic men","volume":"25","author":"Shegem","year":"2004","journal-title":"Saudi Med J"},{"key":"R37-6-20210129","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/humrep\/dep466","article-title":"Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response","volume":"25","author":"Palomba","year":"2010","journal-title":"Hum Reprod"},{"key":"R38-6-20210129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijgo.2009.04.022","article-title":"Short-term metformin treatment for clomiphene citrate-resistant women with polycystic ovary syndrome","volume":"107","author":"Kazerooni","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"R39-6-20210129","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/humrep\/dep444","article-title":"Metformin influence on hormone levels at birth, in PCOS mothers and their newborns","volume":"25","author":"Carlsen","year":"2010","journal-title":"Hum Reprod"},{"key":"R40-6-20210129","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijgo.2009.06.022","article-title":"Comparison of metformin treatment and laparoscopic ovarian diathermy in patients with polycystic ovary syndrome","volume":"107","author":"Ashrafinia","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"R41-6-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijgo.2009.08.033","article-title":"Metformin versus laparoscopic ovarian drilling in clomiphene- and insulin-resistant women with polycystic ovary syndrome","volume":"108","author":"Hamed","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"R42-6-20210129","first-page":"671","article-title":"Drug treatments for polycystic ovary syndrome","volume":"79","author":"Radosh","year":"2009","journal-title":"Am Fam Physician"},{"key":"R44-6-20210129","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/humrep\/deq100","article-title":"PCOSMIC: a multicentre randomized trial in women with polycystic ovary syndrome evaluating metformin for infertility with clomiphene","volume":"25","author":"Johnson","year":"2010","journal-title":"Hum Reprod"},{"key":"R45-6-20210129","doi-asserted-by":"crossref","first-page":"577.e1","DOI":"10.1016\/j.ajog.2009.11.042","article-title":"Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial","volume":"202","author":"Palomba","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"R46-6-20210129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/09513590903366996","article-title":"Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women","volume":"26","author":"Raffone","year":"2010","journal-title":"Gynecol Endrocrinol"},{"key":"R47-6-20210129","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/01443610903147576","article-title":"Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in vitro fertilisation treatment: a randomised controlled trial","volume":"29","author":"Qublan","year":"2009","journal-title":"J Obstet Gynaecol"},{"key":"R48-6-20210129","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/jwh.2009.1491","article-title":"Effects of oral contraceptives and metformin on the outcome of in vitro maturation in infertile women with polycystic ovary syndrome","volume":"19","author":"Zhao","year":"2010","journal-title":"J Womens Health (Larchmt)"},{"key":"R49-6-20210129","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1477-7827-8-45","article-title":"Pregnancy outcome in women with polycystic ovary syndrome comparing the effects of laparoscopic ovarian drilling and clomiphene citrate stimulation in women pretreated with metformin: a retrospective study","volume":"8","author":"Ott","year":"2010","journal-title":"Reprod Biol Endocrinol"},{"key":"R52-6-20210129","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.fertnstert.2008.08.087","article-title":"Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"92","author":"Palomba","year":"2009","journal-title":"Fertil Steril"},{"key":"R54-6-20210129","first-page":"444","article-title":"Metformin and glitazones: do they really help PCOS patients?","volume":"56","author":"Pillai","year":"2007","journal-title":"J Fam Pract"},{"key":"R55-6-20210129","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.fertnstert.2009.08.006","article-title":"Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin","volume":"93","author":"Harris-Glocker","year":"2010","journal-title":"Fertil Steril"},{"key":"R56-6-20210129","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/humrep\/del069","article-title":"Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality","volume":"21","author":"Hahn","year":"2006","journal-title":"Hum Reprod"},{"key":"R57-6-20210129","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1210\/jc.2009-1674","article-title":"Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial","volume":"94","author":"Banaszewska","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R59-6-20210129","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2265.2009.03678.x","article-title":"Atorvastatin pretreatment augments the effect of metformin in patients with polycystic ovary syndrome (PCOS)","volume":"72","author":"Sathyapalan","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R60-6-20210129","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/humrep\/den182","article-title":"Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?","volume":"23","author":"Moll","year":"2008","journal-title":"Hum Reprod"},{"key":"R61-6-20210129","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-07-0294","article-title":"Metformin improves polycystic ovary syndrome symptoms irrespective of pretreatment insulin resistance","volume":"157","author":"Tan","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"R62-6-20210129","first-page":"1431","article-title":"Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.","volume":"1422-","author":"Shu","year":"2007","journal-title":"J Clin Invest"},{"key":"R63-6-20210129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1517\/14728214.7.1.165","article-title":"Insulin-sensitising agents: beyond thiazolidinediones","volume":"7","author":"Perry","year":"2002","journal-title":"Expert Opin Emerg Drugs"},{"key":"R64-6-20210129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.biochem.70.1.341","article-title":"Peroxisome proliferator-activated receptor gamma and metabolic disease","volume":"70","author":"Willson","year":"2001","journal-title":"Annu Rev Biochem"},{"key":"R65-6-20210129","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.2337\/diabetes.50.5.1158","article-title":"Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability","volume":"50","author":"Oakes","year":"2001","journal-title":"Diabetes"},{"key":"R66-6-20210129","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/diabetes.51.3.797","article-title":"The effects of rosiglitazone on insulin sensitivity, lipolysis and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes","volume":"51","author":"Mayerson","year":"2002","journal-title":"Diabetes"},{"key":"R67-6-20210129","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/sj.bjp.0707452","article-title":"Thiazolidinediones: effects on insulin resistance and the cardiovascular system","volume":"153","author":"Quinn","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R68-6-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7326\/0003-4819-134-1-200101020-00014","article-title":"Nonhypoglycemic effects of thiazolidinediones","volume":"134","author":"Parulkar","year":"2001","journal-title":"Ann Intern Med"},{"key":"R69-6-20210129","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.numecd.2009.04.011","article-title":"Peroxisome proliferator-activated receptors and angiogenesis","volume":"19","author":"Biscetti","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R71-6-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/eje.1.01948","article-title":"Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in nonobese young women with polycystic ovary syndrome","volume":"153","author":"Tarkun","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R72-6-20210129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3132\/dvdr.2008.022","article-title":"Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes","volume":"5","author":"Kapoor","year":"2008","journal-title":"Diab Vasc Dis Res"},{"key":"R73-6-20210129","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1089\/jwh.2008.0812","article-title":"Rosiglitazone as treatment for clomiphene citrate-resistant polycystic ovary syndrome: factors associated with clinical response","volume":"17","author":"Shokeir","year":"2008","journal-title":"J Womens Health (Larchmt)"},{"key":"R74-6-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/humrep\/dei312","article-title":"Rosiglitazone and ethinyl estradiol\/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance","volume":"21","author":"Lemay","year":"2006","journal-title":"Hum Reprod"},{"key":"R75-6-20210129","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0015-0282(02)04843-4","article-title":"Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome","volume":"79","author":"Ghazeeri","year":"2003","journal-title":"Fertil Steril"},{"key":"R76-6-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1071-5576(02)00260-5","article-title":"Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy","volume":"10","author":"Shobokshi","year":"2003","journal-title":"J Soc Gynecol Investig"},{"key":"R77-6-20210129","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/jama.298.10.1189","article-title":"Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis","volume":"298","author":"Singh","year":"2007","journal-title":"JAMA"},{"key":"R78-6-20210129","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"R79-6-20210129","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1001\/jama.2010.788","article-title":"Critics press FDA to act on evidence of rosiglitazone's cardiac safety issues","volume":"303","author":"Mitka","year":"2010","journal-title":"JAMA"},{"key":"R80-6-20210129","doi-asserted-by":"crossref","first-page":"c1848","DOI":"10.1136\/bmj.c1848","article-title":"Rosiglitazone, marketing and medical science","volume":"340","author":"Moynihan","year":"2010","journal-title":"BMJ"},{"key":"R81-6-20210129","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2004-1965","article-title":"Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome","volume":"90","author":"Ortega-Gonzalez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R82-6-20210129","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/humrep\/deg343","article-title":"Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin","volume":"18","author":"Glueck","year":"2003","journal-title":"Hum Reprod"},{"key":"R83-6-20210129","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.fertnstert.2009.02.029","article-title":"Effects of pioglitazone on ovarian stromal blood flow, ovarian stimulation, and in vitro fertilization outcome in patients with polycystic ovary syndrome","volume":"94","author":"Kim","year":"2010","journal-title":"Fertil Steril"},{"key":"R84-6-20210129","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"92","author":"Moran","year":"2009","journal-title":"Fertil Steril"},{"key":"R85-6-20210129","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R86-6-20210129","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1701-2163(16)34504-2","article-title":"Ovulation induction in polycystic ovary syndrome","volume":"32","author":"Vause","year":"2010","journal-title":"J Obstet Gynaecol Can"},{"key":"R87-6-20210129","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome.","volume":"23","year":"2008","journal-title":"Hum Reprod"},{"key":"R88-6-20210129","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/AOG.0b013e3181bd12cb","article-title":"ACOG Practice Bulletin No. 108: polycystic ovary syndrome.","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R90-6-20210129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1592\/phco.25.2.244.56943","article-title":"Thiazolidinediones for treatment of polycystic ovary syndrome","volume":"25","author":"Stout","year":"2005","journal-title":"Pharmacotherapy"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GCO.0b013e32833e1264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:16:47Z","timestamp":1620951407000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001703-201012000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0b013e32833e1264","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}